Alpha-Naphthylisocyanate

Alpha-Naphthylisocyanate

SCHEMBL29400034

O=C=Nc1cccc2ccccc12

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.64
ALDH1A1 P00352 5/20 0.64
CYP3A4 P08684 4/20 0.64
HSD17B10 Q99714 4/20 0.64
HPGD P15428 3/20 0.64
TDP1 Q9NUW8 2/20 0.64
ABCB11 O95342 1/20 0.64
NR3C1 P04150 1/20 0.64
ADRA2A P08913 1/20 0.64
ADORA3 P0DMS8 1/20 0.64
ALOX15 P16050 1/20 0.64
ADRA2C P18825 1/20 0.64
MAOA P21397 1/20 0.64
DRD1 P21728 1/20 0.64
SLC6A4 P31645 1/20 0.64
HTR2B P41595 1/20 0.64
CCR2 P41597 1/20 0.64
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alpha-Naphthylisocyanate SCHEMBL374 1.00 CYP1A2 (0.64) CYP1A2ALDH1A1CYP3A4HSD17B10HPGD
Alpha-Naphthylisocyanate SCHEMBL3333508 0.98 CYP1A2 (0.62) CYP1A2ALDH1A1CYP3A4HSD17B10HPGD
Alpha-Naphthylisocyanate SCHEMBL3338004 0.96 CYP1A2 (0.60) CYP1A2ALDH1A1CYP3A4HSD17B10HPGD
Alpha-Naphthylisocyanate SCHEMBL27296117 0.94 CYP1A2 (0.58) CYP1A2ALDH1A1CYP3A4HSD17B10HPGD
SCHEMBL22210 0.86 CYP3A4 (0.62) CYP1A2ALDH1A1CYP3A4HSD17B10HPGD
SCHEMBL29370250 0.86 CYP3A4 (0.62) CYP1A2ALDH1A1CYP3A4HSD17B10HPGD
Alpha-Naphthylisocyanate SCHEMBL11673586 0.85 CYP3A4 (0.49) CYP1A2ALDH1A1CYP3A4HSD17B10HPGD
SCHEMBL5971050 0.84 CYP3A4 (0.47) CYP1A2ALDH1A1CYP3A4HSD17B10HPGD
SCHEMBL9229488 0.83 CYP3A4 (0.54) CYP1A2ALDH1A1CYP3A4HSD17B10HPGD
SCHEMBL194924 0.82 CYP1A2 (0.69) CYP1A2ALDH1A1CYP3A4HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121570289-A Evaluation method for bilirubin adsorption performance of blood perfusion device 健帆生物科技集团股份有限公司 2026-02-27 CN claimed
EP-4185626-A1 SYNTHESIS OF LINEAR POLYOXAZOLIDINONES USING URETDIONES AS DIISOCYANATE COMPONENT BASF SE (DE) 2023-05-31 EP claimed
EP-4731689-A1 METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE Covestro Deutschland AG (DE) 2026-04-29 EP disclosed
EP-4200352-B1 METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE COVESTRO DEUTSCHLAND AG (DE) 2025-11-19 EP disclosed
EP-4200351-B1 METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE COVESTRO DEUTSCHLAND AG (DE) 2025-11-19 EP disclosed
EP-4200353-B1 METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE COVESTRO DEUTSCHLAND AG (DE) 2025-11-19 EP disclosed
EP-4448605-B1 PROCESS FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE COVESTRO DEUTSCHLAND AG (DE) 2025-11-19 EP disclosed
US-12466913-B2 Method for the production of a thermoplastic polyoxazolidinone COVESTRO DEUTSCHLAND AG (DE) 2025-11-11 US disclosed
US-12378348-B2 Method for the production of a thermoplastic polyoxazolidinone COVESTRO DEUTSCHLAND AG (DE) 2025-08-05 US disclosed
EP-4551566-A1 NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS Les Laboratoires Servier (FR) 2025-05-14 EP disclosed
US-20250092272-A1 UV CROSSLINKABLE INKS AND THE USE THEREOF THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2025-03-20 US disclosed
EP-4008736-A1 METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS Covestro Deutschland AG (DE) 2022-06-08 EP disclosed
WO-2022101343-A1 CERIUM-ETHYLENEDIAMINE KETONE-TYPE AND CERIUM-SALEN-TYPE COMPLEXES AND USE THEREOF IN ORGANIC ELECTRONICS Credoxys GmbH (DE) 2022-05-19 WO disclosed
EP-3997152-A1 PROCESS FOR PRODUCING NDI PREPOLYMERS Lanxess Corporation (US) 2022-05-18 EP disclosed
WO-2022043125-A1 METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE COVESTRO DEUTSCHLAND AG (DE) 2022-03-03 WO disclosed
WO-2022043127-A1 METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE COVESTRO DEUTSCHLAND AG (DE) 2022-03-03 WO disclosed
WO-2022043126-A1 METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE COVESTRO DEUTSCHLAND AG (DE) 2022-03-03 WO disclosed
EP-3960786-A1 METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXYZOLIDINONE Covestro Deutschland AG (DE) 2022-03-02 EP disclosed
EP-3960785-A1 METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS Covestro Deutschland AG (DE) 2022-03-02 EP disclosed
EP-3960787-A1 METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE Covestro Deutschland AG (DE) 2022-03-02 EP disclosed